Skip to main content

Proquin XR FDA Approval History

FDA Approved: Yes (Discontinued) (First approved May 19, 2005)
Brand name: Proquin XR
Generic name: ciprofloxacin
Dosage form: Extended-Release Tablets
Company: Depomed, Inc.
Treatment for: Urinary Tract Infection

Marketing Status: Discontinued

Proquin XR (ciprofloxacin) is an extended release fluoroquinolone antibiotic indicated for the treatment of urinary tract infections.

Development timeline for Proquin XR

May 19, 2005Approval Proquin XR Depomed, Inc. - Treatment for Uncomplicated Urinary Tract Infections
Sep 20, 2004Depomed Announces Proquin XR NDA Accepted by FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.